| [1] Coffey A, Ross R P. Bacteriophage-resistance systems in dairy starter strains:molecular analysis to application. Antonie Van Leeuwenhoek, 2002, 82(1-4):303-321.
[2] Doudna J A, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science, 2014,346(6213):1258096.
[3] Mojica F J. Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology, 2009,155(Pt 3):733-740.
[4] Jiang W. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol, 2013,31(3):233-239.
[5] Mali P. RNA-guided human genome engineering via Cas9. Science, 2013,339(6121):823-826.
[6] Garneau J E. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature, 2010,468(7320):67-71.
[7] Makarova K S. Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol, 2011,9(6):467-477.
[8] Jinek M. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 2012,337(6096):816-821.
[9] Fu Y. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol, 2013,31(9):822-826.
[10] Pattanayak V. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol, 2013,31(9):839-843.
[11] Fu Y, Sander D. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol, 2014,32(3):279-284.
[12] Ran F A, Hsu P D, Lin C Y,et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell, 2013,154(6):1380-1389.
[13] Yu C, Liu Y, Ma T, et al. Small molecules enhance CRISPR genome editing in pluripotent stem cells. Cell Stem Cell, 2015,16(2):142-147.
[14] Maruyama T. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat Biotechnol, 2015,33(5):538-542.
[15] Gilbert L A, Horlbeck M A,Adamson B,et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell, 2014,159(3):647-661.
[16] Sanjana N E, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods, 2014,11(8):783-784.
[17] Cong L, Ran F A, Cox D,et al. Multiplex genome engineering using CRISPR/Cas systems. Science, 2013,339(6121):819-823.
[18] Zhou X, Xin J, Fan N, et al. Generation of CRISPR/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer. Cell Mol Life Sci, 2015,72(6):1175-1184.
[19] Wang X, Huang J, Cao C,et al. One-step generation of triple gene-targeted pigs using CRISPR/Cas9 system. Sci Rep, 2016,6:20620.
[20] Hai T. One-step generation of knockout pigs by zygote injection of CRISPR/Cas system. Cell Res, 2014,24(3):372-375.
[21] Wang X, Zhou J, Cao C, et al. Efficient CRISPR/Cas9-mediated biallelic gene disruption and site-specific knockin after rapid selection of highly active sgRNAs in pigs. Sci Rep, 2015,5:13348.
[22] Xue W, Chen S, Yin H, et al. CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature, 2014,514(7522):380-384.
[23] Maresch R, Mueller S, Veltkamp C, et al. Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice. Nat Commun, 2016,7:10770.
[24] Yang D, Xu J, Zhu T, et al. Effective gene targeting in rabbits using RNA-guided Cas9 nucleases. J Mol Cell Biol, 2014,6(1):97-99.
[25] Chen Y, Zheng Y, Kang Y, et al. Functional disruption of the dystrophin gene in rhesus monkey using CRISPR/Cas9. Hum Mol Genet, 2015,24(13):3764-3774.
[26] Wu Y, et al. Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell, 2013,13(6):659-662.
[27] Zhou X, Wang L, Du Y. Efficient generation of gene-modified pigs harboring precise orthologous human mutation via CRISPR/Cas9-induced homology-directed repair in zygotes. Hum Mutat, 2016,37(1):110-118.
[28] Yin H, Xue W, Chen S, et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat Biotechnol, 2014,32(6):551-553.
[29] Reyes L M, Estvada J L, Wang Z Y, et al. Creating class I MHC-null pigs using guide RNA and the Cas9 endonuclease. J Immunol, 2014,193(11):5751-5757.
[30] Yang L, Guell M, Niu D, et al. Genome-wide inactivation of porcine endogenous retroviruses (PERVs). Science, 2015,350(6264):1101-1104.
[31] Drost J, Jaarsveld R H, Ponsioen B, et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature, 2015,521(7550):43-47.
[32] Jiang J, Zhang L, Zhou X, et al. Induction of site-specific chromosomal translocations in embryonic stem cells by CRISPR/Cas9. Sci Rep, 2016,6:21918.
[33] Xie F, Ye L, Chang J C, et al. Seamless gene correction of beta-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac. Genome Res, 2014,24(9):1526-1533.
[34] Howden S E, Maufort J P, Duffin B M, et al. Simultaneous reprogramming and gene correction of patient fibroblasts. Stem Cell Reports, 2015,5(6):1109-1118.
[35] Firth A L, Menson T, Parker G S, et al. Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs. Cell Rep, 2015,12(9):1385-1390.
[36] Chang C W, Lai Y S, Westin E, et al. Modeling human severe combined immunodeficiency and correction by CRISPR/Cas9-enhanced gene targeting. Cell Rep, 2015,12(10):1668-1677.
[37] Wu Y, Zhou H, Fan X, et al. Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells. Cell Res, 2015,25(1):67-79.
[38] Beil-Wagner J, Dossinger G, Schober K, et al. T cell-specific inactivation of mouse CD2 by CRISPR/Cas9. Sci Rep, 2016,6:21377.
[39] Schumann K, Lin S, Boyer E, et al. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proc Natl Acad Sci U S A, 2015,112(33):10437-10442.
[40] Seeger C, Sohn J A. Complete spectrum of CRISPR/Cas9-induced mutations on HBV cccDNA. Mol Ther, 2016,24(7):1258-1266.
[41] Lin S R, Yang H C,Kuo Y T,et al. The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo. Mol Ther Nucleic Acids, 2014,3:e186.
[42] Zetsche B, Gootenberg J S, Abudayyeh O,et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell, 2015,163(3):759-771.
[43] Gao F, Shen X Z, Jiang F,et al. DNA-guided genome editing using the Natronobacterium gregoryi Argonaute. Nat Biotech, 2016, advance online publication. |
